Seroxat, which is manufactured by GlaxoSmithKline, is one of the most commonly prescribed antidepressants. But some who have taken it have claimed they became hooked on the drug, while others have ...

In October, the MHRA reviewed data from the earliest trials of Seroxat. The information was supplied by GlaxoSmithKline in the late Eighties, and it was the MHRA's responsibility to analyse the ...

The GlaxoSmithKline website was also searched for relevant studies on paroxetine. Outcome measures were the Clinical Global Impressions scale, the Children's Depression Rating Scale-Revised ...

SSRIs, such as Pfizer’s Zoloft (sertraline) and GSK’s Paxil (paroxetine), are associated with side effects like dizziness, ...

SSRIs, such as Pfizer’s Zoloft (sertraline) and GSK’s Paxil (paroxetine), are associated with side effects like dizziness, weight gain, and sexual dysfunction. These side effects can affect patients’ ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...